RxDoctor Payments Data

Jason Nakken, DO

Interventional Pain Medicine · Provo, UTNPI 1356755094

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,744 of the $5,986 with a category attached, or 62.5%. 25 manufacturers reported payments, led by Medtronic at 25.0% of the total. Reporting peaked in 2019 at $3,390 and has fallen 97.5% since, to $84 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in UT, where the typical reported total is $7,299.

$5,986in general payments, 2019–2025

Across 183 payments — averaging $32.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Vertiflex, Inc.$1K
  • Boston Scientific$766
  • SPR Therapeutics, Inc$748
  • Nevro Corp.$535
  • Zyla Life Sciences, Inc.$171
  • plus $915 from 19 others

What the payments were for

  • Travel & lodging$2,24237%
  • Food & beverage$3,74463%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,986 in reported general payments places this provider in the 40th percentile of 26 interventional pain medicine providers in Utah.

See all interventional pain medicine providers in Utah

Medicare billing

Part B allowed, 2024
$64,265
Medicare patients
113
Services billed
1,726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ArexvyRsvpref3 Antigen/As01e/Pf17$5,028
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen65$2,314
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen68$1,777
Oxycodone Hcl105$1,438
Buprenorphine Hcl17$1,192
Morphine Sulfate ErMorphine Sulfate33$531
Pregabalin16$518
Morphine Sulfate16$393
Mirtazapine12$233
Tizanidine Hcl19$207
Tramadol Hcl17$193
Gabapentin18$174
Methocarbamol11$172
Diazepam11$34

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →